DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
Current Location:
>
>
> This Story

Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Molecular Imaging Homepage

MILabs selected by Columbia University Irving Medical Center for upgrades to its molecular imaging capabilities

Blue Earth Diagnostics continues to expand access to Axumin (fluciclovine (18F)) in Europe

NRC calls for additional feedback on training and experience requirements for radiopharmaceuticals requiring a written directive

SHINE breaks ground on medical isotope production facility

MR Solutions' PET/MRI scanner explores innovative magnetic nanoparticles as a bimodal imaging agent

ITM builds new production site in Munich area

NorthStar Medical closes $100 million financing with Oberland Capital to expand domestic Mo-99 radioisotope production capacity

Zionexa completes a second $5 million capital raise

SNMMI and ACR collaborate on clinical data registry for nuclear medicine

New PET imaging biomarker could better predict progression of Alzheimer's disease

TRIUMF receives historic investment in 2019 federal budget

Press releases may be edited for formatting or style
Today, the Government of Canada reaffirmed its longstanding support for TRIUMF with the announcement of a $292.7M investment over five years to support laboratory operations. This funding represents the largest single investment in TRIUMF to date. It comes in response to the bold vision presented in TRIUMF's recently published Five-Year Plan 2020-2025. Details of the new funding were included in the 2019 federal budget, which was announced today in Ottawa.

TRIUMF is grateful for this strong support and appreciates the Government of Canada’s sustained commitment to science and innovation. Today’s investment will bolster TRIUMF’s broad portfolio of activities across three core pillars: science and technology; people and skills; and innovation and collaboration. It builds on Canada’s strength in science and research and will help ensure the nation’s continued competitiveness in the global knowledge economy.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



TRIUMF’s Five-Year Plan 2020-2025 lays out a blueprint for TRIUMF’s future, grounded in three state-of-the-art platforms:

The Advanced Rare Isotope Laboratory (ARIEL), a multidisciplinary research facility for isotope research in science, medicine, and business;

The Institute for Advanced Medical Isotopes (IAMI), a world-class centre for the research and development of new isotope-based medical technologies; and

TRIUMF Innovations, a commercialization engine translating TRIUMF’s discoveries into commercial opportunities.

With this support, the laboratory will be well-positioned to realize its mission of delivering discovery and innovation, inspiration and education, and knowledge and opportunity for all. “Today’s announcement sends a strong message of support for Canadian science and its role in Canada’s research and innovation ecosystem,” said TRIUMF Director Dr. Jonathan Bagger. “TRIUMF’s vision is for Canada to lead not only in discovery but also in technology, innovation, and training, so that our country will continue to develop the people and skills necessary for translating science to society. These goals lie at the heart of our Five-Year Plan 2020-2025. We are grateful to the Canadian government for its show of confidence in our vision for Canada’s future.”

“This investment from the federal government will allow TRIUMF to realize its full potential,” said Dr. Digvir Jayas, Chair of the TRIUMF Board of Management. “By leveraging ARIEL, IAMI, and TRIUMF Innovations, TRIUMF will continue to be a global leader in translating science and technology into innovation and commercialization. Today’s announcement represents a major milestone for the lab’s community of university members, researchers, students, users, industry partners and collaborators, and for all the people the lab serves.”

“Five-Year Plan 2020-2025 is the product of extensive consultation with the Canadian research community, TRIUMF’s university members, and the laboratory’s large number of public and private-sector partners,” explained Dr. Reiner Kruecken, TRIUMF’s Deputy Director, Research. “The government’s ongoing support for the laboratory’s operations validates the direction set out the Plan, and TRIUMF looks forward to delivering impact to stakeholders across our multidisciplinary suite of programs.”

Molecular Imaging Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED